IPC The Hospitalist Company Adds Post-Acute Practice in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
IPC The Hospitalist Company Adds Post-Acute Practice in Alabama

NORTH HOLLYWOOD, Calif., July 29, 2013 (GLOBE NEWSWIRE) -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM ), a leading national hospitalist physician group, announced today that it is expanding in Alabama with the acquisition of Baldwin Physician Services, Inc. (BPS), a post-acute hospitalist practice headquartered in Mobile.

R. Jeffrey Taylor, President and Chief Operating Officer of IPC, stated, "IPC entered Alabama in 2011 by contracting with an acute care hospital in Mobile. Since that time, IPC has organically expanded to three hospitals in this market. The acquisition of BPS is a natural next step for us to further improve the quality of patient care across the care continuum. We already have a solid and established working relationship with the BPS team, and we look forward to their participation in the IPC family of practices."

BPS owners Wendell Erdman, M.D. and William Admire, Jr., D.O. will continue to lead the practice under IPC. "The IPC-BPS relationship is already well established, and we are pleased to come together under the IPC banner," noted Dr. Erdman.  "Acute and post-acute hospitalists working closely together to ensure a smooth transition of patient care helps to reduce incidence of re-hospitalization, while improving the overall experience for patients and their families."

The BPS acquisition represents approximately 13,000 encounters on an annualized basis.

About IPC The Hospitalist Company, Inc.

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM ) is a leading physician group practice company focused on the delivery of hospitalist medicine and related facility-based services. IPC's physicians and affiliated providers practice in hospitals or other inpatient facilities, including acute, post-acute and long-term care settings. The Company offers its providers the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of patient care in the facilities it serves. For more information, visit the IPC website at www.hospitalist.com .

Media Contact: Scott Public Relations Elaine Murphy 818.610.0270 Investor Contact: PondelWilkinson Evan Pondel 310.279.5980

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

PotlatchDeltic Reveals Tax Implications for 2024 Shareholder Dividends

Updated Category News Views 247

PotlatchDeltic Reveals Dividend Tax Treatment for 2024 PotlatchDeltic Corporation (Nasdaq: PCH) is stepping into the spotlight by announcing the tax treatment for its anticipated dividend distributions throughout the year. As a prominent player in the real estate investment sector, this announcement brings clarity to investors regarding how dividends will be categorized...

Continue Reading
Beyond Air Secures $3.25 Million from Warrant Exercises

Updated Category News Views 158

Beyond Air's Strategic Moves to Boost Capital Beyond Air, Inc. (NASDAQ: XAIR), a leading medical device and biopharmaceutical company, is making waves in the financial realm. Focused on the innovative use of nitric oxide (NO) to enhance patient care, Beyond Air has announced the immediate exercise of certain outstanding warrants, aiming to generate approximately $3.25...

Continue Reading
Dr. Sven Kili Joins Saisei Ventures as New Partner

Updated Category News Views 194

Saisei Ventures Welcomes Dr. Sven Kili as Partner Saisei Ventures, a prominent investment firm focused on the advancement of biotechnology and therapeutic innovations, has announced an exciting new chapter in its journey. Dr. Sven Kili, MD, has been appointed as a partner, marking a significant addition to the team's leadership. Dr. Kili, who played an advisory role since...

Continue Reading
MangoRx Unveils Innovative Tirzepatide Tablet for Weight Loss

Updated Category News Views 192

Mangoceuticals, Inc. (NASDAQ: MGRX) launched its new oral Tirzepatide tablet, TRIM, back in 2024 at a steep price of $399 per month. Traders noticed this shift towards a convenient alternative to traditional injectables and were already debating the long-term implications on sales and market share. TRIM's Role: A Game Changer for Weight Management? Tirzepatide has made...

Continue Reading
Mama’s Creations Q2 FY2025 Earnings Call Announcement

Updated Category News Views 77

Mama’s Creations to Host Earnings Call for Second Quarter FY2025 Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh deli prepared foods, is preparing to announce its financial results for the fiscal second quarter, which ended on July 31. The earnings call is scheduled to take place after the market closes on September 10....

Continue Reading